The much-anticipated era of disease-modifying therapy for Alzheimer’s disease has at last dawned, promising significant changes in how the condition is perceived and managed.
Guide yourself through this transition with our carefully designed independent Alzheimer’s disease education program, led by world renowned experts and covering the biggest international conferences and disclosures across 2024.
This program is available in English, French, Spanish, Italian, German, Japanese and Simplified Chinese. Register in your preferred language before you start.
Join the journey to a new era for Alzheimer’s disease.
Led by Program Director, Professor Charlotte Teunissen, this program is designed for your individual needs and learning preferences, follow the learning path and pick up the latest news, views, and insights from our experts, with take-away resources and reflective quizzes.
A wide range of topics will be covered including advances in diagnostic tools, applicability of new and emerging biomarkers, and the latest data and experience with novel disease-modifying therapies.
We will take you on a journey from AD/PD in Lisbon, to CONy in London, followed by AAIC in Philadelphia and finally, CTAD in Madrid. You can also earn valuable Continuing Medical Education (CME) points along the way.
We know your time is precious so we have mapped a journey that enables you to access what you need when you need it.
Do you have any questions or comments for our experts? Go to the question hub, open throughout 2024.
As we progress through the year, different areas of the course will become available to you with the question hub open at all times. Earn badges as you engage with the content along the journey. Click on the different icons to access the multimedia content.
Start your journey
AD/PD™️ 2024
Lisbon, Portugal
March 5 – 9, 2024
AD/PD™️ focuses on basic science and translational and clinical research in Alzheimer’s disease and Parkinson’s disease, bringing key advances in disease mechanisms, innovative therapies, and diagnostic biomarkers.
World Congress on Controversies in Neurology (CONy)
London, England
March 21-23, 2024
CONy focuses on commonly debated topics and controversial issues faced by clinicians in neurology, helping them to understand the discrepancies between opposing points of view. In 2024, Alzheimer’s is one of the key topics.
Access conference resources
Alzheimer’s Association International Conference
Philadelphia, USA
July 28 – Aug. 1, 2024
AAIC is the largest international conference on dementia research, providing a forum to share breaking research discoveries in prevention and treatment and improvement in diagnosis for Alzheimer’s disease.
Access conference resources
Clinical Trials on Alzheimer’s Disease Conference
Madrid, Spain
October 29 – November 1, 2024
CTAD is a conference entirely focused on therapeutic trials in Alzheimer’s disease, featuring leaders in the Alzheimer’s field from both research and academia with the aim of progressing effective treatments.
Access conference resourcesExperts in Conversation: highlights from CTAD
Earn CME credits
Meet the experts
(in alphabetical order)
Professor Charlotte Teunissen
Program Director
Professor of Neurochemistry,
Chair of Neurochemistry Lab
Amsterdam UMC, The Netherlands
Professor Sharon A Brangman
Professor and Chair of the Department of Geriatrics, SUNY Upstate Medical University, NY, USA
Dr Petrice Cogswell
Radiologist, Mayo Clinic, MN, USA
Dr Juan Fortea
Director, Memory Unit, Neurology Department at Hospital de la Santa Creu i Sant Pau, Spain
Dr Lea Grinberg
Professor of Neurology and Pathology, University of California, San Francisco, CA, USA
Professor Oskar Hansson
Professor of Neurology,
Senior Consultant in Neurology
Lund University, Sweden
Dr Argonde van Harten
Neurologist, Amsterdam UMC, The Netherlands
Professor Michelle Mielke
Professor of Epidemiology & Professor of Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, USA
Dr Rik Ossenkoppele
Associate Professor of Translational Neuroscience, Amsterdam UMC, The Netherlands & Lund University, Sweden
Professor Claire Paquet
University Professor, Université de Paris Cité, France
Dr Robert Perneczky
Professor of Translational Dementia Research,
Director of the Division of Mental Health in Older Adults and Alzheimer Therapy and Research Center at Ludwig-Maximilians-University Munich and German Center for Neurodegenerative Diseases, Germany
Professor Zvezdan Pirtošek
Professor of Neurology and Professor of Cognitive Neuroscience and is currently serving as Head of Neurology at the Medical Faculty at the University of Ljubljana, Slovenia
Professor Dorota Religa
Professor of Geriatrics, Department of Neurobiology, Care Science and Society, Deputy Head of Clinical Geriatrics, Karolinska Institute, Sweden
Professor Craig Ritchie
Professor of Brain Health and Neurodegenerative Medicine, University of St Andrews, Scotland
Dr Gemma Salvadó
Associate Researcher, Lund University, Sweden
Dr Suzanne E. Schindler
Associate Professor of Neurology, Washington University School of Medicine, USA
